×
About 454 results

ALLMedicine™ Stem Cell Disorders Center

Research & Reviews  223 results

Clinical Insights into the Origins of Thrombosis in Myeloproliferative Neoplasms.
https://doi.org/10.1182/blood.2020008043
Blood Moliterno AR, Ginzburg YZ et. al.

Nov 25th, 2020 - The Philadelphia chromosome negative myeloproliferative neoplasms (MPNs), polycythemia vera, essential thrombocythemia, and primary myelofibrosis, are hematopoietic stem cell disorders that are defined by activating mutations in signal transductio...

Co-existence of mutations in myeloproliferative neoplasms and their clinical significan...
https://doi.org/10.1080/17474086.2020.1819232
Expert Review of Hematology; Homaei Hadad E, Pezeshki SMS et. al.

Sep 4th, 2020 - Myeloproliferative neoplasms (MPNs) are a group of clonal hematopoietic stem cell disorders that may occur after one or more mutations in hematopoietic progenitor cells. In this study, we will review the co-existence of mutations (especially dual ...

Guideline-based indicators for adult patients with myelodysplastic syndromes.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448599
Blood Advances; Stojkov K, Silzle T et. al.

Aug 25th, 2020 - Myelodysplastic syndromes (MDSs) represent a heterogeneous group of hematological stem cell disorders with an increasing burden on health care systems. Evidence-based MDS guidelines and recommendations (G/Rs) are published but do not necessarily t...

Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North A...
https://doi.org/10.1002/pbc.28652
Pediatric Blood & Cancer REFERENCES; Nakano TA, Lau BW et. al.

Aug 11th, 2020 - Myelodysplastic syndromes (MDS) represent a group of clonal hematopoietic stem cell disorders that commonly progress to acute myeloid leukemia (AML). The diagnostics, prognostics, and treatment of adult MDS are established but do not directly tran...

see more →

Clinicaltrials.gov  227 results

Fast Five Quiz: High-Risk Myelodysplastic Syndrome
https://reference.medscape.com/viewarticle/943966

Feb 2nd, 2021 - Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders with an inherent tendency for leukemic transformation. MDS may involve one, two, or three myeloid hematopoiesis cell lineages — erythrocytic, granulocytic, megak...

Clinical Insights into the Origins of Thrombosis in Myeloproliferative Neoplasms.
https://doi.org/10.1182/blood.2020008043
Blood Moliterno AR, Ginzburg YZ et. al.

Nov 25th, 2020 - The Philadelphia chromosome negative myeloproliferative neoplasms (MPNs), polycythemia vera, essential thrombocythemia, and primary myelofibrosis, are hematopoietic stem cell disorders that are defined by activating mutations in signal transductio...

Co-existence of mutations in myeloproliferative neoplasms and their clinical significan...
https://doi.org/10.1080/17474086.2020.1819232
Expert Review of Hematology; Homaei Hadad E, Pezeshki SMS et. al.

Sep 4th, 2020 - Myeloproliferative neoplasms (MPNs) are a group of clonal hematopoietic stem cell disorders that may occur after one or more mutations in hematopoietic progenitor cells. In this study, we will review the co-existence of mutations (especially dual ...

Guideline-based indicators for adult patients with myelodysplastic syndromes.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448599
Blood Advances; Stojkov K, Silzle T et. al.

Aug 25th, 2020 - Myelodysplastic syndromes (MDSs) represent a heterogeneous group of hematological stem cell disorders with an increasing burden on health care systems. Evidence-based MDS guidelines and recommendations (G/Rs) are published but do not necessarily t...

Diagnosis and treatment of pediatric myelodysplastic syndromes: A survey of the North A...
https://doi.org/10.1002/pbc.28652
Pediatric Blood & Cancer REFERENCES; Nakano TA, Lau BW et. al.

Aug 11th, 2020 - Myelodysplastic syndromes (MDS) represent a group of clonal hematopoietic stem cell disorders that commonly progress to acute myeloid leukemia (AML). The diagnostics, prognostics, and treatment of adult MDS are established but do not directly tran...

see more →

News  3 results

Fast Five Quiz: High-Risk Myelodysplastic Syndrome
https://reference.medscape.com/viewarticle/943966

Feb 2nd, 2021 - Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal stem cell disorders with an inherent tendency for leukemic transformation. MDS may involve one, two, or three myeloid hematopoiesis cell lineages — erythrocytic, granulocytic, megak...

Topics in Pediatric Leukemia -- Myelodysplastic and Myeloproliferative Disorders of Childhood
https://www.medscape.com/viewarticle/498645

Introduction The myelodysplastic and myeloproliferative syndromes are rare in childhood, accounting for about 3% of childhood malignancies.[1] They consist of a heterogeneous group of clonal stem cell disorders characterized by ineffective hematop...

see more →